Skip to main content
. 2020 Feb 20;23(3):401–405. doi: 10.1089/jpm.2018.0632

Table 1.

Baseline Characteristics

  All, N = 41,463, N (%) Decedents, n (%) Survivors, n (%) p*
    14,512 (35) 25,951 (65)  
Age       <0.001
 65–74 18,901 (45.6) 5399 (28.6) 13,502 (71.4)  
 75–79 7708 (18.6) 2624 (34.0) 5084 (66.0)  
 80–84 6877 (16.6) 2760 (40.1) 4117 (59.9)  
 85–89 5167 (12.5) 2220 (43.0) 2947 (57.0)  
 ≥90 2810 (6.8) 1390 (49.5) 1420 (50.5)  
Sex       0.53
 Male 21,245 (51.2) 7397 (34.8) 13,848 (65.2)  
 Female 20,208 (48.7) 6991 (34.6) 13,217 (65.4)  
Race       <0.001
 White 26,471 (63.8) 9537 (36.0) 16,934 (64.0)  
 Black 9718 (23.4) 2936 (30.2) 6782 (69.8)  
 Other 5284 (12.7) 1920 (36.4) 3354 (63.6)  
Principal diagnosis (N = 35,036)       <0.001
 Sepsis 11,952 (33.2) 5136 (42.9) 6836 (57.1)  
 Respiratory failure 9297 (26.5) 2069 (22.3) 7228 (77.8)  
 Cerebrovascular disease 5460 (15.6) 3016 (55.2) 2444 (44.8)  
 Myocardial infarction 1801 (5.1) 774 (43.0) 1027 (57.0)  
 Epilepsy and convulsions 1219 (3.5) 77 (6.3) 1142 (93.7)  
 Pneumonia 848 (2.4) 265 (31.3) 583 (68.8)  
 Congestive heart failure 799 (2.3) 195 (24.4) 604 (75.6)  
 Aspiration pneumonitis 755 (2.2) 219 (29.0) 536 (71.0)  
 COPD 598 (1.7) 82 (13.7) 516 (86.3)  
 Cardiac dysrhythmias 485 (1.4) 162 (33.4) 323 (66.6)  
Charlson Comorbidity Index       <0.001
 0 4032 (9.7) 1264 (31.4) 2768 (68.7)  
 1–2 16,277 (39.3) 5699 (35.0) 10,578 (65.0)  
 3–4 12,730 (30.7) 4283 (33.6) 8447 (66.4)  
 >4 8424 (20.3) 3147 (37.4) 5277 (62.6)  
*

p-Value based on Kruskal-Wallis testing.